Viewing Study NCT04250051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-02-27 @ 2:21 PM
Study NCT ID: NCT04250051
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-13
First Post: 2020-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Northwestern University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Acute Myeloid Leukemia View
None Recurrent Myelodysplastic Syndrome View
None Recurrent Myeloproliferative Neoplasm View
None Refractory Acute Myeloid Leukemia View
None Refractory Myelodysplastic Syndrome View
Keywords: